Skip to main content
IMS 19th World Congress on Menopause

IMS 19th World Congress on Menopause

Missed Out? Join IMS2024 On Demand!

About AMS

About AMS

AMS Members

AMS Members

Health Professionals

Consumer Information

Consumer Information

Workplaces

Workplaces

World Menopause Day 2024

World Menopause Day 2024

Menopause Hormone Therapy (MHT) | Stay informed

AMS Statement 15 July 2024

The Australasian Menopause Society (AMS) provides education to health professionals to improve the healthcare of women at perimenopause and after menopause.

The AMS welcomes discussion of menopause and efforts to improve access to appropriate care. However, we have recently become aware of spurious claims being made about menopause and hormone therapy by some health professionals on social media and in opinion pieces. These claims are presented as mainstream expert opinion, but some of them do not accord with current evidence-based guidelines.

Menopausal Hormone Therapy (MHT) discontinuation and shortages Oct 2024

There are a number of MHTs that are currently unavailable. Please note that the TGA has approved some unregistered products under Section 19A and some substitute doses are currently in supply in Australia.

Pharmacists are encouraged to contact suppliers Medsurge Healthcare Pty Ltd on 1300 788 261 for orders of Estramon and Sandoz on 1800 726 369 for orders of Estradiol Transdermal System.

AMS Features

Members login to see more articles.

AMS eLearning

The courses available here are in response to requests from many GPs for up to date evidence-based information and guidance in managing women’s midlife health issues including menopause. 

AMS Member Access
The courses are available free for AMS Members. 

Non AMS Member Access
Site registration is free of charge. Courses are available on a pay for enrolment basis through PayPal.